Enterococcus faecalis: Difference between revisions
(Created page with "==Background== ==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== {| class="wikitable" | align="center" style="background:#f0f0f0;"|'''Organis...") |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | ||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|'''Organisms''' | | align="center" style="background:#f0f0f0;"|'''Organisms''' | ||
Revision as of 20:45, 25 March 2014
Background
Antibiotic Sensitivities[1]
| Organisms | ' | Enterococcus faecalis |
| Penicillins | Penicillin G | + |
| Penicillin V | + | |
| Anti-Staphylocccal Penicillins | Methicillin | 0 |
| Nafcillin/Oxacillin | 0 | |
| Cloxacillin/Diclox. | 0 | |
| Amino-Penicillins | AMP/Amox | + |
| Amox/Clav | + | |
| AMP-Sulb | + | |
| Anti-Pseudomonal Penicillins | Ticarcillin | +/- |
| Ticar-Clav | +/- | |
| Pip-Taxo | + | |
| Carbapenems | Piperacillin | + |
| Doripenem | +/- | |
| Ertapenem | 0 | |
| Imipenem | + | |
| Meropenem | +/- | |
| Aztreonam | 0 | |
| Fluroquinolones | Ciprofloxacin | ^^ |
| Ofloxacin | ^^ | |
| Pefloxacin | 0 | |
| Levofloxacin | + | |
| Moxifloxacin | + | |
| Gemifloxacin | + | |
| Gatifloxacin | + | |
| 1st G Cephalosporin | Cefazolin | 0 |
| 2nd G. Cephalosporin | Cefotetan | 0 |
| Cefoxitin | 0 | |
| Cefuroxime | 0 | |
| 3rd/4th G. Cephalosporin | CefoTAXime | 0 |
| Cefizoxime | 0 | |
| CefTRIAXone | 0 | |
| Ceftobiprole | + | |
| Ceftaroline | + | |
| CefTAZidime | 0 | |
| Cefepime | 0 | |
| Oral 1st G. Cephalosporin | Cefadroxil | 0 |
| Cephalexin | 0 | |
| Oral 2nd G. Cephalosporin | Cefaclor/Loracarbef | 0 |
| Cefproxil | 0 | |
| Cefuroxime axetil | 0 | |
| Oral 3rd G. Cephalosporin | Cefixime | 0 |
| Ceftibuten | 0 | |
| Cefpodox/Cefdinir/Cefditoren | 0 | |
| Aminoglycosides | Gentamicin | S |
| Tobramycin | S | |
| Amikacin | S | |
| Chloramphenicol | +/- | |
| Clindamycin | 0 | |
| Macrolides | Erythromycin | 0 |
| Azithromycin | 0 | |
| Clarithromycin | 0 | |
| Ketolide | Telithromycin | +/- |
| Tetracyclines | Doxycycline | 0 |
| Minocycline | 0 | |
| Glycylcycline | Tigecycline | + |
| Glyco/Lipoclycopeptides | Vancomycin | + |
| Teicoplanin | + | |
| Telavancin | + | |
| Fusidic Acid | + | |
| Trimethoprim | + | |
| TMP-SMX | + | |
| Urinary Agents | Nitrofurantoin | + |
| Fosfomycin | + | |
| Other | Rifampin | +/- |
| Metronidazole | 0 | |
| Quinupristin dalfoppristin | 0 | |
| Linezolid | + | |
| Daptomycin | + | |
| Colistimethate | 0 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2010